SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000947871-16-001418
Filing Date
2016-08-12
Accepted
2016-08-12 17:21:33
Documents
2
Group Members
ORBIMED ADVISORS ISRAEL II LTDORBIMED CAPITAL GP VI LLCORBIMED ISRAEL GP II, L.P.SAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ss6484_sc13d.htm SC 13D 200368
2 JOINT FILING AGREEMENT ss6484_ex99n.htm EX-99.N 17521
  Complete submission text file 0000947871-16-001418.txt   219489
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D

Mailing Address 5 OPPENHEIMER STREET REHOVOT L3 76701
Business Address 5 OPPENHEIMER STREET REHOVOT L3 76701 972-3-6449556
SteadyMed Ltd. (Subject) CIK: 0001619087 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88774 | Film No.: 161829223
SIC: 2834 Pharmaceutical Preparations